Assertio Therapeutics Inc (ASRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Sales | 12,132 | 16,522 | 21,218 | 83,101 | 20,858 |
| Cost of Goods | 619 | 1,150 | 2,140 | 1,635 | 1,136 |
| Gross Profit | 11,513 | 15,372 | 19,078 | 81,466 | 19,722 |
| Operating Expenses | 24,937 | 24,832 | 25,214 | -16,708 | 18,646 |
| Operating Income | -12,805 | -9,310 | -5,996 | 98,809 | 1,212 |
| Interest Expense | 1 | 24 | 39 | 69 | 102 |
| Other Income | -289 | 410 | 357 | 79 | 589 |
| Pre-tax Income | -13,095 | -8,924 | -5,678 | 98,819 | 1,699 |
| Income Tax | 741 | -348 | 1 | 2 | -5 |
| Net Income Continuous | -13,836 | -8,576 | -5,679 | 98,817 | 1,704 |
| Net Income | $-13,836 | $-8,576 | $-5,679 | $98,817 | $1,706 |
| EPS Basic Total Ops | -1.16 | -0.60 | -0.44 | 7.40 | 0.08 |
| EPS Basic Continuous Ops | -1.18 | -0.62 | -0.42 | 7.41 | 0.13 |
| EPS Diluted Total Ops | -1.00 | -0.60 | -0.44 | 7.08 | 0.08 |
| EPS Diluted Continuous Ops | -1.01 | -0.62 | -0.42 | 7.09 | 0.13 |
| EBITDA(a) | $-12,617 | $-9,201 | $-6,022 | $98,958 | $1,320 |